Compare GLP-1 Medications
Find detailed comparisons between different GLP-1 medications. Learn about their similarities, differences, and unique features to better understand your options.
Ozempic vs Wegovy
GLP-1Weight Loss: 12-14% vs 15-17%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction, Obesity Treatment
FDA Approval: Ozempic (2017), Wegovy (2021)
Ozempic vs Saxenda
GLP-1Weight Loss: 12-14% vs 5-10%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction, Obesity Treatment
FDA Approval: Ozempic (2017), Saxenda (2014)
Ozempic vs Mounjaro
MixedWeight Loss: 12-14% vs 15-20%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction, Blood Sugar Control
FDA Approval: Ozempic (2017), Mounjaro (2022)
Ozempic vs Zepbound
MixedWeight Loss: 12-14% vs 15-20%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction, Obesity Treatment
FDA Approval: Ozempic (2017), Zepbound (2023)
Ozempic vs Trulicity
GLP-1Weight Loss: 12-14% vs 2-6%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction
FDA Approval: Ozempic (2017), Trulicity (2014)
Ozempic vs Byetta
GLP-1Weight Loss: 12-14% vs 2-6%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction
FDA Approval: Ozempic (2017), Byetta (2005)
Ozempic vs Bydureon
GLP-1Weight Loss: 12-14% vs 2-4%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction
FDA Approval: Ozempic (2017), Bydureon (2012)
Ozempic vs Lyxumia
GLP-1Weight Loss: 12-14% vs 2-4%
Uses: Type 2 Diabetes, Weight Management, Cardiovascular Risk Reduction
FDA Approval: Ozempic (2017), Lyxumia (2016)
Wegovy vs Saxenda
GLP-1Weight Loss: 15-17% vs 5-10%
Uses: Weight Management, Obesity Treatment
FDA Approval: Wegovy (2021), Saxenda (2014)
Wegovy vs Mounjaro
MixedWeight Loss: 15-17% vs 15-20%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes, Blood Sugar Control
FDA Approval: Wegovy (2021), Mounjaro (2022)
Wegovy vs Zepbound
MixedWeight Loss: 15-17% vs 15-20%
Uses: Weight Management, Obesity Treatment
FDA Approval: Wegovy (2021), Zepbound (2023)
Wegovy vs Trulicity
GLP-1Weight Loss: 15-17% vs 2-6%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes, Cardiovascular Risk Reduction
FDA Approval: Wegovy (2021), Trulicity (2014)
Wegovy vs Byetta
GLP-1Weight Loss: 15-17% vs 2-6%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Wegovy (2021), Byetta (2005)
Wegovy vs Bydureon
GLP-1Weight Loss: 15-17% vs 2-4%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Wegovy (2021), Bydureon (2012)
Wegovy vs Lyxumia
GLP-1Weight Loss: 15-17% vs 2-4%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Wegovy (2021), Lyxumia (2016)
Saxenda vs Mounjaro
MixedWeight Loss: 5-10% vs 15-20%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes, Blood Sugar Control
FDA Approval: Saxenda (2014), Mounjaro (2022)
Saxenda vs Zepbound
MixedWeight Loss: 5-10% vs 15-20%
Uses: Weight Management, Obesity Treatment
FDA Approval: Saxenda (2014), Zepbound (2023)
Saxenda vs Trulicity
GLP-1Weight Loss: 5-10% vs 2-6%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes, Cardiovascular Risk Reduction
FDA Approval: Saxenda (2014), Trulicity (2014)
Saxenda vs Byetta
GLP-1Weight Loss: 5-10% vs 2-6%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Saxenda (2014), Byetta (2005)
Saxenda vs Bydureon
GLP-1Weight Loss: 5-10% vs 2-4%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Saxenda (2014), Bydureon (2012)
Saxenda vs Lyxumia
GLP-1Weight Loss: 5-10% vs 2-4%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Saxenda (2014), Lyxumia (2016)
Mounjaro vs Zepbound
GLP-1/GIPWeight Loss: 15-20% vs 15-20%
Uses: Type 2 Diabetes, Weight Management, Blood Sugar Control, Obesity Treatment
FDA Approval: Mounjaro (2022), Zepbound (2023)
Mounjaro vs Trulicity
MixedWeight Loss: 15-20% vs 2-6%
Uses: Type 2 Diabetes, Weight Management, Blood Sugar Control, Cardiovascular Risk Reduction
FDA Approval: Mounjaro (2022), Trulicity (2014)
Mounjaro vs Byetta
MixedWeight Loss: 15-20% vs 2-6%
Uses: Type 2 Diabetes, Weight Management, Blood Sugar Control
FDA Approval: Mounjaro (2022), Byetta (2005)
Mounjaro vs Bydureon
MixedWeight Loss: 15-20% vs 2-4%
Uses: Type 2 Diabetes, Weight Management, Blood Sugar Control
FDA Approval: Mounjaro (2022), Bydureon (2012)
Mounjaro vs Lyxumia
MixedWeight Loss: 15-20% vs 2-4%
Uses: Type 2 Diabetes, Weight Management, Blood Sugar Control
FDA Approval: Mounjaro (2022), Lyxumia (2016)
Zepbound vs Trulicity
MixedWeight Loss: 15-20% vs 2-6%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes, Cardiovascular Risk Reduction
FDA Approval: Zepbound (2023), Trulicity (2014)
Zepbound vs Byetta
MixedWeight Loss: 15-20% vs 2-6%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Zepbound (2023), Byetta (2005)
Zepbound vs Bydureon
MixedWeight Loss: 15-20% vs 2-4%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Zepbound (2023), Bydureon (2012)
Zepbound vs Lyxumia
MixedWeight Loss: 15-20% vs 2-4%
Uses: Weight Management, Obesity Treatment, Type 2 Diabetes
FDA Approval: Zepbound (2023), Lyxumia (2016)
Trulicity vs Byetta
GLP-1Weight Loss: 2-6% vs 2-6%
Uses: Type 2 Diabetes, Cardiovascular Risk Reduction
FDA Approval: Trulicity (2014), Byetta (2005)
Trulicity vs Bydureon
GLP-1Weight Loss: 2-6% vs 2-4%
Uses: Type 2 Diabetes, Cardiovascular Risk Reduction
FDA Approval: Trulicity (2014), Bydureon (2012)
Trulicity vs Lyxumia
GLP-1Weight Loss: 2-6% vs 2-4%
Uses: Type 2 Diabetes, Cardiovascular Risk Reduction
FDA Approval: Trulicity (2014), Lyxumia (2016)
Byetta vs Bydureon
GLP-1Weight Loss: 2-6% vs 2-4%
Uses: Type 2 Diabetes
FDA Approval: Byetta (2005), Bydureon (2012)
Byetta vs Lyxumia
GLP-1Weight Loss: 2-6% vs 2-4%
Uses: Type 2 Diabetes
FDA Approval: Byetta (2005), Lyxumia (2016)
Bydureon vs Lyxumia
GLP-1Weight Loss: 2-4% vs 2-4%
Uses: Type 2 Diabetes
FDA Approval: Bydureon (2012), Lyxumia (2016)
Medical Disclaimer: These comparisons are for informational purposes only. Always consult with your healthcare provider to determine which medication is most appropriate for your specific situation.
Track Your GLP-1 Journey with ShotWise
Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.
Download ShotWise